These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

706 related articles for article (PubMed ID: 30043289)

  • 1. Iron metabolism in diabetes-induced Alzheimer's disease: a focus on insulin resistance in the brain.
    Chung JY; Kim HS; Song J
    Biometals; 2018 Oct; 31(5):705-714. PubMed ID: 30043289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins.
    Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G
    J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.
    Pardeshi R; Bolshette N; Gadhave K; Ahire A; Ahmed S; Cassano T; Gupta VB; Lahkar M
    Psychoneuroendocrinology; 2017 Sep; 83():159-171. PubMed ID: 28624654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.
    Rad SK; Arya A; Karimian H; Madhavan P; Rizwan F; Koshy S; Prabhu G
    Drug Des Devel Ther; 2018; 12():3999-4021. PubMed ID: 30538427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease.
    Zhao WQ; Townsend M
    Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects.
    Al-Kuraishy HM; Al-Gareeb AI; Saad HM; Batiha GE
    Inflammopharmacology; 2023 Jun; 31(3):1107-1115. PubMed ID: 36849855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.
    Kang S; Lee YH; Lee JE
    Yonsei Med J; 2017 May; 58(3):479-488. PubMed ID: 28332351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme binding to Amyloid-beta peptide: mechanistic role in Alzheimer's disease.
    Atamna H
    J Alzheimers Dis; 2006 Nov; 10(2-3):255-66. PubMed ID: 17119291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.
    Sun Y; Ma C; Sun H; Wang H; Peng W; Zhou Z; Wang H; Pi C; Shi Y; He X
    J Diabetes Res; 2020; 2020():4981814. PubMed ID: 32083135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 3 Diabetes and Its Role Implications in Alzheimer's Disease.
    Nguyen TT; Ta QTH; Nguyen TKO; Nguyen TTD; Giau VV
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron and Targeted Iron Therapy in Alzheimer's Disease.
    Wang J; Fu J; Zhao Y; Liu Q; Yan X; Su J
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
    Stanley M; Macauley SL; Holtzman DM
    J Exp Med; 2016 Jul; 213(8):1375-85. PubMed ID: 27432942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-β and islet amyloid pathologies link Alzheimer's disease and type 2 diabetes in a transgenic model.
    Wijesekara N; Ahrens R; Sabale M; Wu L; Ha K; Verdile G; Fraser PE
    FASEB J; 2017 Dec; 31(12):5409-5418. PubMed ID: 28808140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Review on Neuro-degenerative Type 3 DM.
    Chandarana CV; Roy S
    Curr Diabetes Rev; 2022; 18(8):e131221198790. PubMed ID: 34961464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function.
    Takeda S; Sato N; Rakugi H; Morishita R
    Mol Biosyst; 2011 Jun; 7(6):1822-7. PubMed ID: 21431241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.